KA
Kendra Adams sold $122K of CCCC stock
Kendra Adams, Chief Financial Officer of C4 Therapeutics, Inc. (CCCC), sold 45,173 shares of CCCC stock worth $122K, per an SEC Form 4 filed Nov 13, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on Nov 12, 2026, 1 day before it was made public.
CCCC has moved -0.4% since the trade date, from $2.77 to $2.76 (Nov 13, 2026 close).
- Traded
- Nov 12, 2026
- Disclosed
- Nov 13, 2026
- Filing delay
- 1 day
- Price since
- -0.4%
- Role
- Chief Financial Officer
- Source
- SEC Form 4